[Borun] Announcement and Filing by Important Subsidiary Upsher-Smith Laboratories, LLC Pursuant to Article 22, Paragraph 1, Clause 3 of the 'Guidelines for Loans and Guarantees by Publicly Issued Companies'

1. Date of Fact: 115/07/02

2. Recipient of Loan: (1) Company Name: Bora Pharmaceutical Holdings, LLC (2) Relationship with Lending Company: 100% indirectly owned subsidiary of our company (loan provided by subsidiary Upsher-Smith Laboratories, LLC) (3) Loan Limit (in thousand NT$): 14,176,296 (4) Previous Loan Balance (in thousand NT$): 0 (5) Amount of New Loan (in thousand NT$): 798,000 (6) Is this a loan authorized by the board to the chairman for multiple disbursements or revolving use to the same borrower: No (7) Loan Balance as of Fact Date (in thousand NT$): 798,000 (8) Reason for New Loan: Working capital required for obtaining U.S. drug approvals and related rights

3. Collateral Provided by Borrower: (1) Description: None (2) Value (in thousand NT$): 0

4. Borrower's Latest Financial Statements: (1) Capital (in thousand NT$): 32 (2) Accumulated Profits/Losses (in thousand NT$): 880,711

5. Interest Calculation Method: 5.2% per annum

6. Repayment Terms: (1) Conditions: Full repayment of principal and interest at maturity (2) Date: Repayment within one year from the date of borrowing

7. Loan Balance as of Fact Date (in thousand NT$): 798,000

8. Ratio of Loan Balance to Net Equity in the Latest Financial Statements of the Publicly Issued Company: 5.48

9. Source of Loan Funds: Subsidiary's own funds

10. Other Matters to be Disclosed: None